Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study

BACKGROUND: Evidence is lacking for cognitive enhancer therapy in patients with Alzheimer’s disease (AD) and concomitant cerebrovascular disease (mixed AD) as such patients would have been excluded from clinical trials. Earlier studies of mixed AD have focused on large vessel cerebrovascular disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Kok Pin, Ng, Aloysius, Assam, Pryseley, Heng, Esther, Kandiah, Nagaendran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153975/
https://www.ncbi.nlm.nih.gov/pubmed/25063270
http://dx.doi.org/10.1007/s40268-014-0057-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153975/
https://www.ncbi.nlm.nih.gov/pubmed/25063270
http://dx.doi.org/10.1007/s40268-014-0057-5

Ejemplares similares